🟢 Context Therapeutics is trading 5.46% up in pre-market with no confirmed company-specific catalyst identified

Context Therapeutics is trading at $0.49, up 5.46%, after no confirmed company-specific announcement or overnight catalyst was identified for the pre-market move.

• It closed at $0.47 on August 24, 2026.
• The latest investor-relations release, dated August 5, covered second-quarter results and pipeline priorities, including CTIM-76 and CT-202, but does not explain the August 25 movement.
• Broader futures are modestly higher, though the backdrop is not strong enough to establish causation.